Thema
Journal Article
30
Research Support, Non-U.S. Gov't
18
Sunitinib
13
Nivolumab
9
31YO63LBSN
7
Antineoplastic Agents
7
Indoles
7
Pyrroles
7
V99T50803M
7
Antineoplastic Agents, Immunological
5
Randomized Controlled Trial
5
Sorafenib
5
Advanced hepatocellular carcinoma
4
Caregiver
4
Clinical Trial, Phase III
4
Cognitive dysfunction
4
Cost burden
4
Everolimus
4
GBM
4
Gastric cancer
4
Glioblastoma
4
Line of therapy
4
Observational Study
4
Survival
4
Treatment patterns
4
nivolumab
4
Functional Scale
3
Gastroesophageal junction cancer
3
HRQoL Scale
3
Multicenter Study
3
Overall Survival
3
Overall Survival Time
3
Pazopanib
3
Peptide Receptor Radionuclide Therapy
3
Sunitinib Malate
3
survival
3
7673326042
2
9ZOQ3TZI87
2
Adverse events
2
Cancer registry
2
Comparative Study
2
I11
2
Immunotherapy
2
Irinotecan
2
Metastatic renal cell cancer
2
Observational
2
Published Erratum
2
Real-world data
2
Systematic Review
2
Targeted therapy
2
mehr ...